- Home
- ARVN vs RES Comparison
ARVN vs RES Comparison
Compare ARVN & RES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- RES
- Stock Information
- Founded
- ARVN 2015
- RES 1984
- Country
- ARVN United States
- RES United States
- Employees
- ARVN N/A
- RES N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- RES Oilfield Services/Equipment
- Sector
- ARVN Health Care
- RES Energy
- Exchange
- ARVN Nasdaq
- RES Nasdaq
- Market Cap
- ARVN 1.4B
- RES 1.3B
- IPO Year
- ARVN 2018
- RES N/A
- Fundamental
- Price
- ARVN $18.57
- RES $6.98
- Analyst Decision
- ARVN Strong Buy
- RES Sell
- Analyst Count
- ARVN 13
- RES 3
- Target Price
- ARVN $63.00
- RES $6.08
- AVG Volume (30 Days)
- ARVN 860.7K
- RES 1.6M
- Earning Date
- ARVN 02-25-2025
- RES 01-30-2025
- Dividend Yield
- ARVN N/A
- RES 2.27%
- EPS Growth
- ARVN N/A
- RES N/A
- EPS
- ARVN N/A
- RES 0.55
- Revenue
- ARVN $161,100,000.00
- RES $1,474,169,000.00
- Revenue This Year
- ARVN $239.85
- RES N/A
- Revenue Next Year
- ARVN N/A
- RES N/A
- P/E Ratio
- ARVN N/A
- RES $12.61
- Revenue Growth
- ARVN 1.07
- RES N/A
- 52 Week Low
- ARVN $17.08
- RES $5.54
- 52 Week High
- ARVN $53.08
- RES $8.19
- Technical
- Relative Strength Index (RSI)
- ARVN 43.53
- RES 74.41
- Support Level
- ARVN $17.35
- RES $6.10
- Resistance Level
- ARVN $21.00
- RES $7.17
- Average True Range (ATR)
- ARVN 1.18
- RES 0.20
- MACD
- ARVN 0.12
- RES 0.11
- Stochastic Oscillator
- ARVN 38.01
- RES 86.82
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About RES RPC Inc.
RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment consists of pressure pumping, downhole tools, coiled tubing, snubbing, nitrogen, well control, wireline, and fishing. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.